Journals / Türk Nefroloji Diyaliz ve Transplantasyon Dergisi / 2013 / Cilt: 22 - Sayı: 2

Sisplatin nefrotoksisitesinde Nrf2/HO-1’nin thymoquinone tarafından modülasyonu

Modulation of Nrf2/HO-1 by thymoquinone during cisplatin-induced nephrotoxicity

Pages
182–187
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CONCLUSION: This study demonstrates the TQ targets NRF2/HO-1 and can be used as a potential agent against cisplatin-induced nephrotoxicity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: Side effects of cisplatin, such as nephrotoxicity, limit its use in chemotherapeutic regimens and indicate an agent that suppresses its toxicity.
📊
Key Findings & Data:We propose a protective mechanism of of TQ on cisplatin-nephrotoxicity in rats that is through modulation of Nrf2-mediated antioxidant induction and reduced inflammation.
💡
Conclusion & Impact:CONCLUSION: This study demonstrates the TQ targets NRF2/HO-1 and can be used as a potential agent against cisplatin-induced nephrotoxicity.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: Side effects of cisplatin, such as nephrotoxicity, limit its use in chemotherapeutic regimens and indicate an agent that suppresses its toxicity. Thymoquinone (TQ), the predominant bioactive constituent present in black seed oil (Nigella sativa), has antiinflammatory, antioxidant and antitumor effects. We propose a protective mechanism of of TQ on cisplatin-nephrotoxicity in rats that is through modulation of Nrf2-mediated antioxidant induction and reduced inflammation. MATERIAL and METHODS: Twenty-eight male Wistar rats (8 weeks-old) were divided into four groups; Control (vehicle; 0.9% saline, 1 ml/kg body wt., p.o.), TQ (10 mg/kg body weight/day in drinking water for 5 days), cisplatin (a single injection of 7mg/kg body wt, i.p.) and TQ for 5 days in drinking water then a single injection of cisplatin. On day 10, all rats were sacrificed by cervical dislocation, kidneys were removed, and serum urea and creatinine were collected. RESULTS: Serum urea and creatinine levels were significantly higher in cisplatin-treated rats compared with control rats. TQ-treatment significantly decreased serum urea and creatinine levels. Cisplatin-treatment caused significant downregulation of the nuclear NF-E2-related factor-2 (Nrf2), heme oxygenase-1(HO-1) and caused an increase in the levels of nuclear factor-kappa B (NF-κB). Interestingly, TQ supplementation significantly improved the changes associated with cisplatin nephrotoxicity by increasing the levels of Nrf-2 and HO-1 and decreasing the levels of NF-κB. CONCLUSION: This study demonstrates the TQ targets NRF2/HO-1 and can be used as a potential agent against cisplatin-induced nephrotoxicity.

Özet

AMAÇ: Sisplatinin nefrotoksisite gibi sitotoksik etkileri, kemoterapi rejimlerinde kullanımını sınırlamakta ve toksik etkilerini baskılayacak bir ajana gereksinim doğmaktadır. Thymoquinone (TQ) çörek otu yağında bulunan biyoaktif bileşen olup, antiinflamatuvar, antioksidan ve antitümör etkileri vardır. Bu çalışmada, ratlarda TQ’nin Nrf2 indüksiyonu ve antiinflamatuvar etki yoluyla sisplatin nefrotoksisitesi üzerine olan koruyucu etkisini araştırdık. GEREÇ ve YÖNTEMLER: Bu çalışmada, TQ’in sisplatin aracılı nefrotoksisiteye etkisini ve bu süreçte in vivo olarak inflamasyonu baskılama mekanizmalarını araştırdık. Sekiz haftalık 28 erkek Wistar rat 4 gruba ayrıldı; kontrol (1 mg/kg oral %0,9’luk tuz çözeltisi), TQ (5 gün boyunca içme suyuna 10 mg/kg/gün), sisplatin (7 mg/kg, i.p. tek doz) ve içme suyuyla 5 günlük TQ uygulaması sonrası tek doz sisplatin enjeksiyonu yapılan grup. Onuncu günde tüm ratlardan servikal dislokasyon sonrası böbrek dokuları ile üre ve kreatinin ölçümü amaçlı serumları alındı. BULGULAR: Çalışmamız kontrol grubuna kıyasla sisplatin grubunda üre ve kreatinin değerlerinin anlamlı şekilde yüksek olduğunu göstermektedir (p

🔖

Cite This Article

TUZCU, M., GÜREL, A., ULU, R., MUQBIL, I., DOĞUKAN, A., MOHAMMAD, R. M., ŞAHİN, K. (2022). Sisplatin nefrotoksisitesinde Nrf2/HO-1’nin thymoquinone tarafından modülasyonu. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi, Cilt: 22 - Sayı: 2, 182–187. https://ajindex.com/articles/636343

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Rabik CA, Dolan ME: Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev 2007
  2. 23 2. Arany I, Safirstein RL: Cisplatin nephrotoxicity. Semin Nephrol 2003
  3. 464 3. Goldstein RS, Mayor GH: A minireview. The nephrotoxicity of cisplatin. Life Sci 1983
  4. 690 4. Lee KW, Jeong JY, Lim BJ, Chang YK, Lee SJ, Na KR, Shin YT, Choi DE: Sildenafil attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity. Toxicology 2009
  5. 143 5. Yao X, Panichpisal K, Kurtzman N, Nugent K: Cisplatin nephrotoxicity: A review. Am J Med Sci 2007
  6. 124 6. Pabla N, Dong Z: Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies. Kidney Int 2008
  7. 1007 7. Kotnis MS, Patel P, Menon SN, Sane RT: Renoprotective effect of Hemidesmus indicus, a herbal drug used in gentamicin-induced renal toxicity. Nephrology (Carlton) 2004
  8. 152 8. Rao NK, Nammi S: Antidiabetic and renoprotective effects of the chloroform extract of Terminalia chebula Retz. seeds in streptozotocin-induced diabetic rats. BMC Complement Altern Med 2006
  9. 17 9. Shimeda Y, Hirotani Y, Akimoto Y, Shindou K, Ijiri Y, Nishihori T, Tanaka K: Protective effects of capsaicin against cisplatin-induced nephrotoxicity in rats. Biol Pharm Bull 2005
  10. 1638 10. Sahin K, Tuzcu M, Gencoglu H, Dogukan A, Timurkan M, Sahin N, Aslan A, Kucuk O: Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats. Life Sci 2010
  11. 245 11. Sahin K, Tuzcu M, Sahin N, Ali S, Kucuk O: Nrf2/HO-1 signaling pathway may be the prime target for chemoprevention of cisplatin- induced nephrotoxicity by lycopene. Food Chem Toxicol 2010
  12. 2674 12. Sriram N, Kalayarasan S, Sudhandiran G: Epigallocatechin-3- gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2-Keap1 signaling. Pulm Pharmacol Ther 2009
  13. 236 13. Farombi EO, Shrotriya S, Na HK, Kim SH, Surh YJ: Curcumin attenuates dimethylnitrosamine-induced liver injury in rats through Nrf2-mediated induction of heme oxygenase-1. Food Chem Toxicol 2008
  14. 1287 14. Kim J, Cha YN, Surh YJ: A protective role of nuclear factor- erythroid 2-related factor-2 (Nrf2) in inflammatory disorders. Mutat Res 2010
  15. 23 15. Gali-Muhtasib H, Roessner A, Schneider-Stock R: Thymoquinone: A promising anti-cancer drug from natura